Dr. Jacques Archambault is a Professor in the Department of Microbiology and Immunology at McGill University , and an associate member of the Division of Experimental Medicine since 2016. His research focuses on the molecular biology and pathogenesis of human papillomaviruses (HPVs) and polyomaviruses (HPyVs), with an emphasis on their replication mechanisms as episomes in host cells. The Archambault laboratory employs functional genomics, proteomics, and chemical biology approaches to identify cellular pathways exploited by these viruses and develop high-throughput assays for screening small molecule inhibitors of viral replication. Analysis of his recent publications reveals a strong focus on HPV and HPyV replication machinery, including studies on the E1 helicase, UAF1-USP1 interactions, and structural characterization of viral proteins involved in DNA replication. His work bridges virology, oncology, and drug discovery, particularly targeting oncogenic HPV types implicated in anogenital and oropharyngeal cancers, as well as HPyVs like BKPyV and JCPyV that cause pathologies in immunosuppressed patients. Current efforts in the lab aim to elucidate the molecular mechanisms by which HPVs and HPyVs replicate their genomes and to develop antiviral therapies targeting these processes. Techniques such as fluorescence anisotropy, NMR spectroscopy, and crystallography are frequently employed to study protein-DNA and protein-protein interactions critical to viral replication.
Joseph Kangmennaang is an Assistant Professor and Queen's National Scholar in Black Health & Social Change at Queen's University. He holds a PhD from the University of Waterloo, an MA from Western University, and a B.A. from the University of Ghana. His research focuses on the interplay between environment and wellbeing, particularly in sub-Saharan Africa and among Black immigrant communities in North America. He employs social theories, participatory methods, and mixed approaches to address health disparities, with a focus on non-communicable diseases, food/water security, and the impact of racism and social change. His courses include HLTH 397 (Globalization and Black Health) and HLTH 495 (Racism and Health). Research areas include immigrant health equity, syndemics, and the role of place in healthcare access. Collaborations with marginalized communities emphasize participatory action and civic engagement. He has published extensively on topics such as climate change impacts on health, HIV/AIDS knowledge among women in Malawi, and the social determinants of wellbeing in Ghana. His work bridges global health challenges with localized solutions, addressing systemic inequities through interdisciplinary partnerships. Notably, he explores how structural factors like migration, remittances, and agroecology affect household welfare and food security in Malawi and Ghana. His recent studies highlight the mental health implications of discrimination among minoritized Canadians during the pandemic and the spatial distribution of diseases like cholera in Tanzania. He advocates for community-driven interventions to promote wellbeing in resource-limited settings.
Dr. Karen Yeates is a Professor in the Division of Nephrology at Queen's University's School of Medicine. She holds cross-appointments in the Faculty of Health Sciences and is a member of Queen's Cancer Research Institute and Translational Institute of Medicine. Her work focuses on improving healthcare access through mHealth innovations in global settings, particularly sub-Saharan Africa and Indigenous communities. Education: MD (Queen's University), MPH (Harvard School of Public Health), Fellowship in Nephrology (Royal College of Physicians and Surgeons Canada). Research interests span global health equity, cardiovascular disease prevention, cervical cancer screening, and mobile health technology. Key projects include leading the PURE Study Tanzania (Prospective Urban and Rural Epidemiology) and the International Polypill Study for cardiovascular prevention. She pioneered smartphone-based interventions for hypertension management in rural communities and cervical cancer screening in Tanzania. Articles consistently address mHealth implementation, chronic disease epidemiology, and health systems strengthening. Recent work evaluates mobile health tools for malaria prevention and cervical precancer detection in resource-limited settings. Rising Stars in Global Health Award (2024) CIHR-Global Alliance grant for mHealth hypertension projects Principal Investigator for Grand Challenges Canada initiatives Advocates for equitable kidney care globally, contributing to ISN Global Kidney Health Atlas. Co-founded Queen’s University School of Medicine’s Office of Global Health to advance interdisciplinary global health training.
Dr. Anuraag Shrivastav is a Professor at the University of Winnipeg's Department of Biology, affiliated with the Richardson College for the Environment and Science Complex. His research focuses on cellular signaling mechanisms linked to cancer development, particularly studying biomarkers and therapeutic targets for colorectal, breast, and prostate cancers. His lab also explores renewable energy materials, including perovskite solar cells and nanomaterials like zinc oxide buckyballs. Research Interests: Dr. Shrivastav investigates oncogenic pathways involving N-myristoyltransferase (NMT), mTOR signaling, and STAT3/AP1 interactions. His work bridges basic science and clinical applications, developing diagnostic tools such as blood-based biomarker tests. Simultaneously, he pioneers advancements in energy materials through computational modeling and experimental synthesis of novel photovoltaic systems. Publications Trends: Over 2023-2025, his articles emphasize translational cancer research—identifying prognostic markers and therapeutic strategies—while maintaining a parallel focus on materials innovation for sustainable energy solutions. This dual focus reflects his interdisciplinary approach to scientific inquiry. Awards: No specific awards mentioned, though his extensive publication record indicates sustained research impact. He currently supervises graduate students and postdocs in both cancer biology and materials science domains. Lab/Team: His laboratory integrates molecular biology, computational modeling, and materials engineering, fostering cross-disciplinary collaboration. Active projects include NMT-based cancer diagnostics and next-generation solar cell development.
Jarold L. Cosby is an Associate Professor of Kinesiology at Brock University , located in St. Catharines, Ontario. He holds a PhD and leads the Qualitative Research Lab , focusing on healthcare decision-making processes among patients, physicians, and policymakers in both developed and developing nations. His research includes studies on cervical cancer screening protocols in Kenya, pediatric injury prevention, synthetic insulin use, and improving clinical trial methodologies. Dr. Cosby has secured funding from over 25 agencies including the Medical Research Council (UK), World Bank, and Canada Health Infoway. He maintains affiliations as a Grant Reviewer for the Canadian Institutes of Health Research, serves on Brock University’s Research Ethics Board and Senate, and holds editorial roles in journals like Health Services Insights . Teaching focuses include qualitative methods, health promotion, and clinician-patient communication. Notably, he is currently not accepting graduate students for the 2020/21 academic year. Awards: Sir Frederick Banting Grant, Grand Challenges Stars in Global Health Award, Paul Ehrlich Award Key Research Themes: Global health equity, healthcare policy evaluation, qualitative methodologies, clinical trial optimization His lab’s interdisciplinary work bridges clinical practice, policy, and community health in contexts ranging from Kenya’s cervical cancer initiatives to Canadian injury prevention strategies.
Dustin James Costescu is an Associate Professor in the Department of Obstetrics & Gynecology at McMaster University's Faculty of Health Sciences. His research focuses on contraception access and education hormonal impacts on mental health HPV testing for cervical cancer screening maternal health disparities . Recent publications highlight his work in hormonal contraception efficacy , abortion medication availability , and intrauterine device design . His studies often bridge clinical practice with health policy, particularly in underserved populations like incarcerated women. Key collaborations include health technology assessments and clinical guidelines development, with significant engagement in Canadian policy frameworks and medical education innovation .
Dr. Richa Pandey is an Assistant Professor in the Department of Biomedical Engineering at the University of Calgary's Schulich School of Engineering. She serves as a Full Member of the Hotchkiss Brain Institute and is the Principal Investigator of the Wearable and Bio-integrated Technologies (WeBiT) Lab, where she also holds the UCalgary Research Excellence Chair position. Her work bridges biomedical engineering, digital health, and women's health applications. Dr. Pandey earned her Ph.D. in Physical Electronics from Tel Aviv University in 2018. Her educational background provides the foundation for her interdisciplinary research that combines electronics, biomaterials, and medical applications. Dr. Pandey's research focuses on developing innovative healthcare solutions with particular emphasis on women's health challenges including perinatal depression, preeclampsia, cervical cancer, and malaria in pregnancy. Her laboratory specializes in three interconnected research pillars: wearable biosensors for continuous health monitoring, point-of-care diagnostic technologies for decentralized testing, and bioreceptor discovery for enhanced detection systems. These technologies are designed to be accessible, particularly in low-resource settings, addressing significant health inequities through engineering solutions. Her work integrates biology, engineering, and digital health to create medical technologies that are both effective and user-friendly. Analysis of Dr. Pandey's recent publications reveals a strong focus on electrochemical and photoelectrochemical biosensing platforms, with particular emphasis on nucleic acid-based detection systems. Her research spans multiple application areas including infectious disease diagnostics (particularly for SARS-CoV-2), cancer biomarker detection, environmental monitoring, and neurotransmitter sensing. The consistent theme across her work is the development of rapid, sensitive, and field-deployable diagnostic technologies that minimize sample preparation requirements while maintaining high analytical performance. Marie Sklodowska Curie Fellowship, Marie Sklodowska Curie Association Excellence Award, Marian Gertner Institute for Medical Nanosystems Food Security Fellowship, Manna Center for Food Safety and Security Dr. Pandey actively mentors federally and provincially funded students and postdoctoral fellows in her laboratory. Her educational philosophy emphasizes hands-on learning and application of engineering principles to medical challenges. She participates in outreach initiatives that inspire underrepresented groups to pursue engineering careers. Her collaborative approach includes partnerships with clinicians, industry experts, and global health organizations to ensure her research translates into practical, impactful healthcare solutions. Dr. Pandey also teaches multiple courses including BMEN 388 Signals, Systems and Instrumentation I, BMEN 585 Guest Lecture on Point of Care Diagnostics, BMEN 600 Biomedical Engineering Foundations, and BMEN 468 Engineering Design for Biomedical Engineering. The Wearable and Bio-integrated Technologies (WeBiT) Lab serves as the hub for Dr. Pandey's research activities. The laboratory houses federally funded instruments and highly skilled personnel dedicated to developing cutting-edge medical devices. The lab's vision focuses on creating disruptive technologies to engineer health solutions through a multidisciplinary and translational approach. Current projects include Revolutionizing real-time health monitoring through wearable biosensors, Making diagnostics accessible through point-of-care technologies, and developing the foundation of smart sensing through bioreceptor discovery and design.
Maura Marcucci is an Associate Professor (Part-Time) in the Department of Health Research Methods, Evidence, and Impact at McMaster University. Her work focuses on perioperative medicine, frailty assessment, cardiovascular outcomes, and surgical risk management. Dr. Marcucci is actively involved in clinical trials such as the POISE-3 randomized controlled trial evaluating tranexamic acid and hypotension management strategies. She has contributed to guidelines on remote patient monitoring and virtual care post-surgery, emphasizing technology-driven healthcare solutions. Education: Medical degree and advanced training in geriatrics and clinical research (details not explicitly stated in text) Her research integrates epidemiological methods with clinical practice, addressing topics like frailty in cancer patients, postoperative cognitive dysfunction, and anticoagulation strategies. Key projects include the PVC-RAM trials exploring virtual care post-discharge and the FARGO study assessing frailty in gynecologic oncology. Publications highlight interdisciplinary collaborations in areas such as myocardial injury after noncardiac surgery, venous thromboembolism recurrence, and the role of telemedicine in acute care. Current initiatives focus on improving outcomes through personalized perioperative care and reducing hospital readmissions. Dr. Marcucci teaches Fundamentals of Health Research and Evaluation Methods (HTHRSM 721) and contributes to the design of cohort studies like the ArthroCaP project linking chronic pain and cognitive dysfunction after joint surgeries.
Christina Gillies is an Adjunct Professor at the School of Public Health, University of Alberta and a Lead Scientist in Cancer Prevention and Screening Innovation at Alberta Health Services. Her work bridges academic research with community-driven health initiatives. Research Interests: Focuses on community health promotion, social determinants of health, participatory approaches, and nutrition equity. She specializes in qualitative and mixed methods to address health inequities through culturally appropriate interventions. Article Trends: Recent publications emphasize cancer prevention via gardening initiatives, Indigenous school nutrition programs, and social capital interventions for HPV immunization. Themes include SDG 3 (Good Health), SDG 2 (Zero Hunger), and SDG 10 (Reduced Inequalities). Collaborations: Partnerships with Alberta Healthy Communities Approach , Multicultural Health Brokers Co-op , and First Nation community committees shape her applied research.
Ryan Woods is an Assistant Professor in the University of British Columbia's Faculty of Health Sciences and an Executive Director, Data and Analytics at BC Cancer. He holds a Scientist position in the Department of Cancer Control Research at BC Cancer Research Institute. His academic journey includes a PhD in Population and Public Health from UBC, an MSc in Statistics, and a BSc in Mathematics from the University of Guelph. Dr. Woods' research focuses on leveraging administrative and registry data to address cancer control challenges, particularly in oncology outcomes, cancer screening equity, and health system performance. His work emphasizes international benchmarking, equity gaps in service utilization, and data-driven health policy. Key areas include evaluating disparities in breast cancer screening participation among immigrant populations, analyzing pandemic impacts on cancer diagnosis timing, and optimizing team-based cancer care models. His publications span over two decades, with recent emphasis on pandemic-related healthcare disruptions, multimorbidity trends, and global cancer survival disparities. He has contributed to CONCORD-3 and ICBP initiatives analyzing international cancer outcomes. Dr. Woods also leads BC Cancer's data strategy, integrating biostatistics and epidemiology to advance population health surveillance. His expertise bridges clinical and population-level research, with a focus on translating data insights into actionable strategies for improving cancer care equity and system efficiency. Current projects include spatial access analysis for lung screening programs and modeling pandemic-driven health burden shifts.
Elizabeth Pavlovic is an Assistant Teaching Professor in the Faculty of Nursing at the University of New Brunswick, based in Moncton. Her academic background includes a Master of Nursing (2021) and Bachelor of Nursing (2017) from the University of New Brunswick. Her expertise spans oncology, women's health, mental health, and global health, with a strong focus on cervical cancer screening and primary care nursing. Her research explores urgent care nursing and substance use interventions, emphasizing practical healthcare solutions. Recent publications analyze cervical cancer screening barriers and COVID-19 modeling, reflecting her commitment to evidence-based public health strategies. Pavlovic actively contributes to provincial health committees, including the New Brunswick Cervical Cancer Screening Guidelines Committee.
Francis Bui is an Associate Professor in the Department of Electrical and Computer Engineering and Graduate Chair of Biomedical Engineering at the University of Saskatchewan's College of Engineering. His expertise spans Machine Learning, Biomedical Engineering, Signal Processing, Medical Imaging, Information Security, and Wireless Communications. He leads research initiatives in computational biology, medical device innovation, and AI-driven diagnostics. Education: Holds BSc, MSc, and PhD degrees (institutions unspecified). Research interests include biosensor design, federated learning for healthcare, and predictive modeling for disease management. His work integrates machine learning with biomedical applications, focusing on early disease detection and precision medicine. Recent research highlights include developing AI tools for RNA modification analysis, tumor-homing peptides, and SARS-CoV-2 detection biosensors. He also explores cybersecurity in medical systems and federated learning frameworks for privacy-preserving genomics. Notable contributions include optical fiber innovations for biomedical sensing and ensemble learning models for drug target identification. His lab focuses on translating computational methods into clinical applications, emphasizing interdisciplinary collaboration.
Markian Pahuta MD PhD is an Associate Professor of Surgery at McMaster University and an orthopaedic spine surgeon at Hamilton General Hospital, Ontario. Board-certified by the American Board of Orthopaedic Surgery, he completed his MD at the University of Toronto (2004-2008), residency at the University of Ottawa (2008-2015), a Clinician-Investigator Program (2011-2013), and a spine-surgery fellowship at the University Health Network/University of Toronto (2015-2016), followed by a PhD at the University of Ottawa (2013-2019). His practice and research cover the entire spectrum of spinal disorders, with a recent focus on degenerative cervical myelopathy, spinal trauma, oncology, adult deformity, health-economic valuation, and technology-enhanced surgical training. Education & Training PhD, University of Ottawa, 2013-2019 Clinical Fellowship in Spine Surgery, University Health Network/University of Toronto, 2015-2016 Clinician Investigator Program, University of Ottawa, 2011-2013 MD, University of Toronto, 2004-2008 Orthopaedic Surgery Residency, University of Ottawa, 2008-2015 Diplomate, American Board of Orthopaedic Surgery, 2019-2029 Research Interests Dr Pahuta leads Canada-wide observational studies through the Canadian Spine Outcomes and Research Network (CSORN) examining wait-times, opioid utilisation, complication rates, and cost-effectiveness of spine surgery. He publishes systematic reviews and health-economic analyses that define utility scores for metastatic epidural spinal cord compression and degenerative cervical myelopathy, enabling cost-utility and budget-impact evaluations. His surgical oncology work clarifies optimal treatment strategies for patients with intermediate SIN scores and establishes consensus terminology for cancer-related spine pain. He explores augmented- and virtual-reality platforms to enhance competency-based training of spine surgeons and investigates AI-driven automation of spinopelvic parameter measurement. Across more than 120 peer-reviewed articles since 2008, his recent output (2022-2025) clusters into four dominant themes: (1) large-scale prospective cohort analyses of Canadian elective and traumatic spine populations; (2) health-services and economic evaluations that translate patient-reported outcome scores into policy-relevant utility metrics; (3) systematic reviews and meta-analyses that synthesise complication rates, survivorship, and comparative effectiveness of cervical and lumbar procedures; and (4) innovation studies on robotics, navigation, and immersive technologies in surgical education. Scientific Awards & Recognition No specific prizes or named lectureships are listed in the supplied material; however, his work is frequently cited in national guidelines and picked up by mainstream Canadian media (>30 news outlets for one 2023 study). Grants & Advising While explicit grant numbers are not provided, he is the principal architect of multiple CSORN analyses, indicating sustained national funding. No individual graduate students or post-doctoral fellows are named in the available text. Laboratory & Team Dr Pahuta collaborates with the McMaster Spine Program, the CSORN national consortium, the AO Spine Knowledge Forum, and international working groups developing consensus frameworks such as OSCO-M. These multi-institutional teams link clinicians, epidemiologists, health economists, and data scientists across more than 20 Canadian centres and multiple international sites.
Dr. Rein Lepnurm is a Professor at the School of Public Health, University of Saskatchewan. His research focuses on health care policy, medical care organization, and entrepreneurship. He leads studies on quality management in Canadian hospitals and nurse-patient ratio solutions. As Principal Investigator, he secured grants totaling over $200k from CIHR and other agencies. Current courses taught include Health Care Management (PUBH 808), Health Care Economics (PUBH 814), and Canadian Health Care System (PUBH 852). His work emphasizes applied solutions for healthcare challenges through initiatives like the MERCURi Research Group. Recent publications address cervical cancer screening inequities, HPV vaccination awareness in Colombia, and barriers to Indigenous health improvements. Awards include a CIHR grant for patient-centered quality assessment initiatives (2013-2015).
Jean Gauthier serves as a Clinical Lecturer in the Department of Pathology and Cell Biology within the Faculty of Medicine at the University of Montreal. His academic profile centers on diagnostic pathology with clinical applications in oncology. His research concentrates on Anatomo-pathology with specialized focus on gynecologic and urologic malignancies. Key investigation areas include molecular profiling of ovarian cancers, pathological staging of prostate neoplasia, HPV testing methodologies for cervical screening, and biomarker discovery in urological cancers. His work bridges laboratory diagnostics with clinical oncology through histomorphological analysis and molecular characterization. Analysis of his 1996 publications reveals consistent emphasis on cancer biomarkers and diagnostic pathology across multiple tumor types. His research demonstrates particular expertise in translating molecular findings (BRCA1, HER2/neu) into clinical applications for ovarian, prostate, and cervical cancers, with strong representation at national oncology conferences. No scientific awards are documented in the available records. Professional activities include participation in the department's teaching laboratory and Virtual Histology Lab initiatives. No student advising or research grant information is specified in the source material. He maintains active clinical-academic engagement through conference presentations at the Society of Gynecologic Oncologists and Association of Urologists of Quebec, focusing on practical diagnostic and therapeutic challenges in cancer pathology.
